(Q51015187)

English

Long-term treatment with Sitagliptin, a dipeptidyl peptidase-4 inhibitor, reduces colon carcinogenesis and reactive oxygen species in 1,2-dimethylhydrazine-induced rats.

scientific article published on 29 May 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23649733

Long-term treatment with Sitagliptin, a dipeptidyl peptidase-4 inhibitor, reduces colon carcinogenesis and reactive oxygen species in 1,2-dimethylhydrazine-induced rats. (English)

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23649733

reactive oxygen species

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23649733

author name string

Angelo Pietro Femia

1

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23649733

Giulia Maglieri

3

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23649733

Maura Lodovici

4

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23649733

Edoardo Mannucci

5

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23649733

Giovanna Caderni

6

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23649733

language of work or name

0 references

publication date

29 May 2013

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23649733

International Journal of Cancer

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23649733

133

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23649733

10

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23649733

2498-2503

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23649733

Diabetes and cancer: a consensus report.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28260

21 January 2018

Incretin-based therapies for type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28260

21 January 2018

The "cryptic" mechanism of action of glucagon-like peptide-2.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28260

21 January 2018

Glucagon-like peptide-2 does not modify the growth or survival of murine or human intestinal tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28260

21 January 2018

Glucagon-like peptide-1 receptor activation inhibits growth and augments apoptosis in murine CT26 colon cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28260

21 January 2018

Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28260

21 January 2018

Phase II trial of single agent Val-boroPro (Talabostat) inhibiting Fibroblast Activation Protein in patients with metastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28260

21 January 2018

Sustained proliferation and resistance to apoptosis after a cytotoxic insult are early alterations in rat colon carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28260

21 January 2018

Dose translation from animal to human studies revisited

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28260

21 January 2018

Administration of a dipeptidyl peptidase IV inhibitor enhances the intestinal adaptation in a mouse model of short bowel syndrome

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28260

21 January 2018

GLP-1 and cardioprotection: from bench to bedside

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28260

21 January 2018

Marie Ménard apples with high polyphenol content and a low-fat diet reduce 1,2-dimethylhydrazine-induced colon carcinogenesis in rats: effects on inflammation and apoptosis.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28260

21 January 2018

Safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28260

21 January 2018

Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28260

21 January 2018

Exendin-4, but not dipeptidyl peptidase IV inhibition, increases small intestinal mass in GK rats

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28260

21 January 2018

Physiological and Pharmacological Mechanisms through which the DPP-4 Inhibitor Sitagliptin Regulates Glycemia in Mice

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28260

21 January 2018

Identifiers

10.1002/IJC.28260

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23649733

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23649733

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51015187&oldid=1531790613"